Chugai Pharmaceutical Statistics

Total Valuation

CHGCF has a market cap or net worth of 81.88 billion. The enterprise value is 76.55 billion.

Market Cap	81.88B
Enterprise Value	76.55B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	Jun 29, 2026

Share Statistics

Current Share Class	1.65B
Shares Outstanding	n/a
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	19.04%
Float	639.88M

Valuation Ratios

The trailing PE ratio is 28.79 and the forward PE ratio is 24.25.

PE Ratio	28.79
Forward PE	24.25
PS Ratio	10.08
PB Ratio	6.82
P/TBV Ratio	7.04
P/FCF Ratio	34.74
P/OCF Ratio	29.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.95, with an EV/FCF ratio of 32.48.

EV / Earnings	26.92
EV / Sales	9.46
EV / EBITDA	18.95
EV / EBIT	19.96
EV / FCF	32.48

Financial Position

The company has a current ratio of 4.70

Current Ratio	4.70
Quick Ratio	3.67
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	2,957.68

Financial Efficiency

Return on equity (ROE) is 23.71% and return on invested capital (ROIC) is 41.79%.

Return on Equity (ROE)	23.71%
Return on Assets (ROA)	17.38%
Return on Invested Capital (ROIC)	41.79%
Return on Capital Employed (ROCE)	31.60%
Weighted Average Cost of Capital (WACC)	7.55%
Revenue Per Employee	1.59M
Profits Per Employee	557,192
Employee Count	5,104
Asset Turnover	0.59
Inventory Turnover	1.41

Taxes

In the past 12 months, CHGCF has paid 1.07 billion in taxes.

Income Tax	1.07B
Effective Tax Rate	27.32%

Stock Price Statistics

The stock price has decreased by -23.60% in the last 52 weeks. The beta is 0.60, so CHGCF's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-23.60%
50-Day Moving Average	57.70
200-Day Moving Average	51.18
Relative Strength Index (RSI)	36.06
Average Volume (20 Days)	1,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CHGCF had revenue of 8.12 billion and earned 2.84 billion in profits. Earnings per share was 1.73.

Revenue	8.12B
Gross Profit	5.80B
Operating Income	3.85B
Pretax Income	3.91B
Net Income	2.84B
EBITDA	4.02B
EBIT	3.85B
Earnings Per Share (EPS)	1.73

Balance Sheet

The company has 5.35 billion in cash and n/a in debt, giving a net cash position of 5.35 billion.

Cash & Cash Equivalents	5.35B
Total Debt	n/a
Net Cash	5.35B
Net Cash Per Share	n/a
Equity (Book Value)	12.00B
Book Value Per Share	7.29
Working Capital	7.62B

Cash Flow

In the last 12 months, operating cash flow was 2.78 billion and capital expenditures -420.55 million, giving a free cash flow of 2.36 billion.

Operating Cash Flow	2.78B
Capital Expenditures	-420.55M
Depreciation & Amortization	166.95M
Net Borrowing	-54.25M
Free Cash Flow	2.36B
FCF Per Share	n/a

Margins

Gross margin is 71.45%, with operating and profit margins of 47.42% and 35.02%.

Gross Margin	71.45%
Operating Margin	47.42%
Pretax Margin	48.18%
Profit Margin	35.02%
EBITDA Margin	49.48%
EBIT Margin	47.42%
FCF Margin	29.02%

Dividends & Yields

This stock pays an annual dividend of 1.36, which amounts to a dividend yield of 2.51%.

Dividend Per Share	1.36
Dividend Yield	2.51%
Dividend Growth (YoY)	10.63%
Years of Dividend Growth	2
Payout Ratio	99.07%
Buyback Yield	-0.00%
Shareholder Yield	2.50%
Earnings Yield	3.47%
FCF Yield	2.88%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHGCF has an Altman Z-Score of 24.53 and a Piotroski F-Score of 4.

Altman Z-Score	24.53
Piotroski F-Score	4